Harvard University saw a notable financial setback in the 2024 fiscal year, with a net loss of $150 million in donations due to backlash over the Ivy League’s response to antisemitism on its Massachusetts campus.
Harvard was one of the focal points of antisemitic protests and attacks after the Oct. 7 massacre in Israel last year. The university has faced heavy backlash over its handling of the protests and antisemitism in general.
Former Harvard President Claudine Gay even resigned in January after giving a controversial testimony regarding anitsemitism in front of Congress.
Donations were down by $151 million in fiscal year 2024, compared to fiscal year 2023. Donors pulled a total of $193 million from Harvard’s endowment in 2024, but new donations for current use gifts increased by $42 million, according to Fox Business.
“About 8% of fiscal year 2024 operating revenue came from gifts for current use, primarily payments on prior pledges,” Harvard Vice President for Finance Ritu Kalra and Treasurer Timothy Barakett wrote in the university’s financial report. “At over $525 million, current use giving reached the second highest level in Harvard’s history. […]
— Read More: justthenews.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
